These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26083988)

  • 41. Impact of point-of-care international normalized ratio monitoring on quality of treatment with vitamin K antagonists in non-self-monitoring patients: a cohort study.
    Biedermann JS; van Rein N; van den Besselaar AM; Buhre PN; de Maat MP; van der Meer FJ; Leebeek FW; Kruip MJ
    J Thromb Haemost; 2016 Apr; 14(4):695-703. PubMed ID: 26806724
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anticoagulation control and cost of monitoring of older patients on chronic warfarin therapy in three settings in North East England.
    Abohelaika S; Kamali F; Avery P; Robinson B; Kesteven P; Wynne H
    Age Ageing; 2014 Sep; 43(5):708-11. PubMed ID: 24947831
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relation of quality of anticoagulation control with different management systems among patients with atrial fibrillation: Data from FANTASIIA Registry.
    Roldán Rabadán I; Esteve-Pastor MA; Anguita-Sánchez M; Muñiz J; Camacho Siles J; Quesada MA; Ruiz Ortiz M; Marín F; Martínez Sellés M; Bertomeu V; Lip GYH; Cequier Fillat A; Badimón L;
    Eur J Clin Invest; 2018 May; 48(5):e12910. PubMed ID: 29424018
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Control of anticoagulation in patients with non-valvular atrial fibrillation in a primary care clinical practice setting in the different autonomous communities. PAULA study].
    Polo García J; Barrios Alonso V; Escobar Cervantes C; Prieto Valiente L; Lobos Bejarano JM; Vargas Ortega D; Prieto Díaz MÁ; Alonso Moreno FJ; Barquilla García A
    Semergen; 2017 Apr; 43(3):207-215. PubMed ID: 27422774
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quality of Anticoagulation With Vitamin K Antagonists.
    Bertomeu-González V; Anguita M; Moreno-Arribas J; Cequier Á; Muñiz J; Castillo-Castillo J; Sanchis J; Roldán I; Marin F; Bertomeu-Martínez V;
    Clin Cardiol; 2015 Jun; 38(6):357-64. PubMed ID: 25962838
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Time in therapeutic range (TTR) and follow-up of patients on vitamin K antagonist: A cohort analysis].
    Valdelièvre E; Quéré I; Caré B; Laroche JP; Schved JF
    J Med Vasc; 2018 May; 43(3):155-162. PubMed ID: 29754725
    [TBL] [Abstract][Full Text] [Related]  

  • 47. International Normalized Ratio Variability: A Measure of Anticoagulation Quality or a Powerful Mortality Predictor.
    Vanerio G
    J Stroke Cerebrovasc Dis; 2015 Oct; 24(10):2223-8. PubMed ID: 26232891
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The SAME-TT2R2 score predicts the quality of anticoagulation control in patients with acute VTE. A real-life inception cohort study.
    Palareti G; Antonucci E; Lip GY; Testa S; Guazzaloca G; Falanga A; Pengo V; Poli D;
    Thromb Haemost; 2016 Jun; 115(6):1101-8. PubMed ID: 26819229
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comparative study using thrombin generation and three different INR methods in patients on Vitamin K antagonist treatment.
    Riva N; Vella K; Meli S; Hickey K; Zammit D; Calamatta C; Makris M; Kitchen S; Ageno W; Gatt A
    Int J Lab Hematol; 2017 Oct; 39(5):482-488. PubMed ID: 28500649
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effectiveness of anticoagulation with vitamin K antagonists in acute stroke patients with atrial fibrillation--Hungarian results].
    Sas A; Csontos K; Lovász R; Valikovics A
    Ideggyogy Sz; 2015 Jan; 68(1-2):47-51. PubMed ID: 25842916
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anticoagulation control with daily low-dose vitamin k to reduce clinically adverse outcomes and international normalized ratio variability: a systematic review and meta-analysis.
    Lam J; Schulman S; Witt DM; Vandvik PO; Qayyum F; Holbrook AM
    Pharmacotherapy; 2013 Nov; 33(11):1184-90. PubMed ID: 23744743
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assays of fibrin network properties altered by VKAs in atrial fibrillation - importance of using an appropriate coagulation trigger.
    Ząbczyk M; Blombäck M; Majewski J; Karkowski G; Wallen HN; Undas A; He S
    Thromb Haemost; 2015 Apr; 113(4):851-61. PubMed ID: 25518887
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Evaluation of the quality of long-term anticoagulation therapy with antivitamin-K in atrial fibrillation].
    Ben Rejeb O; Brahim W; Ghali H; Ernez S; Mahdhaoui A; Jeridi G
    Ann Cardiol Angeiol (Paris); 2019 Apr; 68(2):80-86. PubMed ID: 30293798
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anticoagulation Control in Older Atrial Fibrillation Patients Receiving Vitamin K Antagonist Therapy for Stroke Prevention.
    Zulkifly H; Lip GYH; Lane DA
    Int J Clin Pract; 2022; 2022():5951262. PubMed ID: 35685589
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation.
    Gallego P; Roldan V; Marín F; Romera M; Valdés M; Vicente V; Lip GY
    Thromb Haemost; 2013 Dec; 110(6):1189-98. PubMed ID: 24096615
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Quality control of oral anticoagulant therapy in Primary Care in Madrid City, Spain: CHRONOS-TAO study].
    Alonso Roca R; Figueroa Guerrero CA; Mainar de Paz V; Arribas García MP; Sánchez Perruca L; Rodríguez Barrientos R; Casado López M; Pedraza Flechas AM
    Med Clin (Barc); 2015 Sep; 145(5):192-7. PubMed ID: 25433789
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.
    Bussey HI; Bussey M; Bussey-Smith KL; Frei CR
    Pharmacotherapy; 2013 Nov; 33(11):1136-46. PubMed ID: 24038412
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Meta-analysis to assess the quality of international normalized ratio control and associated outcomes in venous thromboembolism patients.
    Mearns ES; Kohn CG; Song JS; Hawthorne J; Meng J; White CM; Raut MK; Schein JR; Coleman CI
    Thromb Res; 2014 Aug; 134(2):310-9. PubMed ID: 24935672
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identifying potential predictors of high-quality oral anticoagulation assessed by time in therapeutic international normalized ratio range: a prospective, long-term, single-center, observational study.
    Costa GL; Lamego RM; Colosimo EA; Valacio RA; Moreira Mda C
    Clin Ther; 2012 Jul; 34(7):1511-20. PubMed ID: 22717417
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differences in the quality of oral anticoagulation therapy with vitamin K antagonists in German GP practices - results of the cluster-randomized PICANT trial (Primary Care Management for Optimized Antithrombotic Treatment).
    Mertens C; Siebenhofer A; Berghold A; Pregartner G; Ulrich LR; Mergenthal K; Kemperdick B; Schulz-Rothe S; Rauck S; Harder S; Gerlach FM; Petersen JJ
    BMC Health Serv Res; 2019 Aug; 19(1):539. PubMed ID: 31370840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.